DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Potassium canrenoate
Potassium canrenoate
Specifications of Approved Drug Compound Library
COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-Cov-2 Infection
Mineralocorticoid Receptor Antagonists for Heart Failure with Reduced Ejection Fraction: Integrating Evidence Into Clinical Practice
6. References
Other Data Relevant to an Evaluation of Carcinogenicity and Its Mechanisms
Network-Based Characterization of Drug-Protein Interaction Signatures
Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
Answered On:13.12.2000 Marketing of Drugs Kanti Singh;Raghuvansh Prasad Singh
Dosage and Administration
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Stress-Induced Alterations of Social Behavior Are Reversible by Antagonism of Steroid Hormones in C57/BL6 Mice
Aldactone® Spironolactone Tablets, USP
Formulary 12 Edition
Stembook 2018.Pdf
ALDACTAZIDE- Spironolactone and Hydrochlorothiazide Tablet, Film Coated
Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……
Index Vol. 16-23
Application Note FT-IR: JI-Ap-FT0508-014
Top View
Spironolactone 25 Mg
Spironolactone
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2011/0269704 A1 Seigfried (43) Pub
7.5 G/50Ml Injection 6545 4874
Poisons List (Jersey) Order 1986
Customs Tariff - Schedule
Run Parameters Results Query Molecule
Poisons List (Jersey) Order, 1986. ______
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone In
Customs Tariff - Schedule Xxi - 1
Correlation Between Drug Market Withdrawals and Socioeconomic, Health, and Welfare Indicators Worldwide
Potassium Canrenoate
Harmonized Tariff Schedule of the United States (2006) (Rev
(12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Drugs Formulary
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2006) (Rev
Combined Estrogen-Progestogen Menopausal
Progress in Primary Aldosteronism. Mineralocorticoid Antagonist
SPIRACTIN Presentation Uses
Drug Discovery Kits
WO 2016/063269 Al 28 April 2016 (28.04.2016) P O P C T
Aldosterone As a Target in Congestive Heart Failure Sanjay Rajagopalan*, Bertram Pitt University of Michigan School of Medicine, Ann Arbor, MI, USA
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
West Suffolk Hospital Formulary (Aug 2021)